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Abstract

THE ROLE OF GONADAL HORMONES ON OPIOID RECEPTOR PROTEIN
DENSITY IN ARTHRITIC RATS
Matthew Christopher Kren, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2006
Directory: Dr. Sandra Welch
Associate Professor, Department of Pharmacology and Toxicology

The majority of research on the endogenous opioid system has focused on various
pain assays and the efficacy of different opioid agonists. However, minimal attention has
been focused on the effects of gonadal hormones and their impact on the opioid peptide
system. The present study was designed to determine the effects of modulation of
gonadal hormones on the opioid receptor protein levels in Complete Freund's Adjuvant
(CFA)-treated arthritic and non-arthritic male and female Lewis rats. Midbrain and
spinal cord tissues were collected for comparison of the p, 6, and K receptor protein
levels in arthritic and non-arthritic animals. Male gonadectomy did not dramatically
impact opioid receptor protein levels, whereas female gonadectomy resulted in
significant increases in opioid receptor protein levels. Furthermore, it was determined

that MOR protein levels were greatest in male rats, while KOR protein levels were
greatest in female rats regardless of arthritis condition or gonadal hormones.

Introduction

History of Opioids
Opium, a substance derived from the poppy plant, Papaver somniferum, has been
used throughout history and in almost every culture to alleviate pain and other ailments.
Although much of the early history of opium is unclear, it appears that cultures that used
the juices from the unripe seed of the poppy plant understood its power. Historical
references indicate that the Sumerians were the first civilization to use opium, possibly
first used by priests as a euphoriant in religious ceremonies (Aragon-Poce et al., 2002).
Opium's euphoria and analgesic properties undoubtedly led to its popularity over many
of the herbal drugs used prior to opium. By the thirteen century A.D. opium use had
spread from the Middle East, to Greece, Rome, Asia, and throughout Europe.
Afier opium had been used for centuries to treat ailments such as headaches,
surgical pain, and to produce constipation, its active ingredient was isolated in 1806.
German scientist, Friedrich Serturner, discovered the specific alkaloid in opium
responsible for its profound effects and named it morphine, after the Greek god of
dreams, Morpheus (Brownstein, 1993). Scientists continukd to explore the alkaloids
found in the juices of Papaver somniferum and discovered substances like codeine,
thebaine, and papaverine; however the greatest advances in understanding the effects of

opiates occurred after scientists began to understand and modify the chemical structure of
these alkaloids.
Unfortunately, the analgesic benefits of treatment with opium, morphine, and
codeine were plagued by their ability to produce tolerance and addiction. Heroin was the
first attempt at producing a drug that was able to alleviate pain like morphine, but without
causing addiction. However, after Bayer released heroin in 1898, its claims of providing
non-addictive pain relief were proven false (Corbett et al., 2006). This search to
synthetically produce substances with similar or greater analgesic effects not only led to
the discovery of numerous other opioid drugs, like methadone, oxycodone, and fentanyl,
but also provided a view into the mechanisms that produced the desired analgesia. The
synthetic opioid nalorphine provided the initial insight into the mechanism of opioid
analgesia. Scientists discovered that nalorphine was able to produce analgesia, while
antagonizing the analgesic effects of morphine. The mixed effect of nalorphine was the
action of a mixed agonist-antagonist, which indicated the presence of multiple receptors
within the opioid system (Brownstein, 1993).

Opioid Receptors

As more opioid agonists, antagonists, and mixed agonist-antagonists were
developed and studied the theory of multiple opioid receptors was reaffirmed. The initial
evidence for multiple receptors came from Gilbert and Martin (1976) where they tested
morphine- and nalorphine-like drugs on chronic spinal dogs. Ultimately, it was
determined that there were three opioid receptors working at the same time and named

them according to their agonists, y for morphine, K for ketazocine, and a for Nallylnormetazocine (SKF 10047) (Martin et al., 1976). This discovery was followed by
the subsequent proposal of the 6 receptor in order to explain the activity of enkephalin, a
peptide known at the time to interact with opioid receptors (Lord, 1977).
The overall understanding of the opioid receptors was greatly advanced when the
receptor were successfully cloned in the 1990's. In 1992, the 6 receptor (DOR) was first
to be cloned. (Evans et al., 1992; Kieffer et al., 1992). Then, in 1993, the y receptor
(MOR) (Chen et al., 1993a,b; Fukuda et al., 1993; Thompson et al., 1993) and K receptor
(KOR) (Li et al., 1993; Meng et al., 1993; Minami et al., 1993; Nishi et al., 1993).
However, the a receptor, originally discovered by Martin et al. is no longer considered an
opioid receptor since it lacks the stereoselectivity and antagonism by opioid antagonists
that is characteristic of opioid receptors (Corbett et al., 2006). Then an orphan opioid
receptor, with almost 70% sequence homology to the other opioid receptors, was
identified in 1997 (Henderson and McKnight, 1997). After the discovery of the 'orphan'
receptor, called opioid receptor-like receptor (ORLl), the list of accepted opioid
receptors remains: y, 6, K, and ORLI.

Endogenous Opioid Peptides
Discovering the presence of multiple opioid receptors was pivotal in the
advancement of understanding of the opioid receptor system. Unfortunately, this did not
explain why the juices of the poppy plant had such a profound interaction with the opioid

receptors and were able to produce its popular analgesic effect. These interactions were
explained by the discovery of the endogenous opioid peptides, including the dynorphins,
enkephalins, and endorphins. In 1975, Hughes et al. observed that a substance from
guinea pig brain acted as an agonist at opioid receptors, but its effect was antagonized by
naloxone. This substance was later determined to contain a mixture of the first two
endogenous opioid peptides, methionine-enkephalin and leucine-enkephalin (shortened to
[Met5]-and [Leu5]-enkephalins)(Hughes et al., 1975). Following the discovery of the
enkephalins, opiate-like activity was observed in peptides found in pituitary glands,
which led to another class of endogenous opioid peptides, the dynorphins (Goldstein et
al., 1975). The last class of endogenous opioid peptides, the endorphins, was discovered
with P-endorphin isolated from human and camel pituitary glands (Li and Chung, 1976).
The endogenous opioid peptides are derived from larger peptides found within the
body. Proenkephalin (PENK), Prodynorphin (PDYN), and Pro-opiomelanocortin
(POMC) function as precursor peptides for enkephalins, dynorphins, and B-endorphin,
respectively (Przewlocki R. and Przewlocki B., 2001). Proenkephalin is the source of
[Met5]- and [Leu5]-enkephalinsand several longer peptides, including Peptide E, BAM
22P, and Metorphamide (Corbett et al., 2006). PENK-containing neurons are expressed
in neuronal and nonneuronal sites throughout the central and peripheral nervous system
] - [Leu5]-enkephalinsderived from
(Przewlocki R. and Przewlocki B., 2001). [ ~ e t ~and
PENK have high affinities for DOR. Prodynorphin (PDYN) functions as a precursor
peptide for the dynorphins, alpha and beta neoendorphin, and as the primary source of
[Leu5]-enkephalin. PDYN-containing neurons are localized in areas of the brain and

peripheral nervous system associated with nociception (Watson et al., 1981). Opioid
fragments of PDYN have the greatest affinity for KOR, but also display significant
affinity at MOR and DOR (Corbett et al., 1993).
The peptide pro-opiomelanocortin (POMC) is the source of P-endorphins (1-27)
and several non-opioid peptides. POMC is also the precursor to adrenocorticotropin
hormone (ACTH), melanocyte-stimulating hormone (MSH), and P -1ipotropin.

P-

endorphin peptides bind with similar affinity to MOR and DOR and with a lower affinity
to KOR.

P -endorphin peptides are present in the nucleus arcuatus of the mediobasal

hypothalamus and function in pain response (Przewlocki R. and Przewlocki B., 2001).

G Protein Superfamily
MOR, DOR, KOR, and ORL-1 opioid receptors are members of the G protein
coupled receptor superfamily. G proteins are heterotrimers composed of a , P, and y
subunits bound to either a guanosine diphosphate (GDP) or guanosine triphosphate
binding protein (GTP) (Shaqura et al., 2004). Opioid receptors are coupled to G protein
heterotrimers, which become activated through the binding of a opioid ligand to the
receptor (Forse, 2000). Once activated the G protein changes conformation, resulting in a
decreased affinity for the GDP binding protein (Neer, 1995). After releasing GDP, the a
subunit is activated by binding a GTP, causing the a subunit to dissociate from the Py
subunit. Eventually, the GTP is hydrolyzed from the a subunit by the enzyme GTPase,

resulting in a single GDP. The a and py subunits are then able to reassociate, become
inactive, and return to the receptor (Neer, 1995).
During the G protein cycle once the a and

subunits have dissociated, each

subunit is able produce its effect. The effect of the G proteins can be quite broad;
influencing adenylate cyclase, kinases, phospolipases, and ion-channel exchanges (Forse,
2000). It is the effect of the GPCR that can result in the diminished pain sensation caused
by the opioid system (Shaqura et al., 2004).

Pain
Advances in the study of the opioid system have resulted in dramatic
improvements of our understanding of pain mechanisms and methods of pain treatment.
Pain can be classified into two groups, either acute pain or chronic pain. Acute pain is
associated with tissue damage or injury that results from trauma or surgery. This form of
pain is essential as part of a survival instinct to protect from further damage and to allow
for recovery. However, chronic pain occurs as the result of disease, such as autoimmune
mediated diseases. Some of the most common examples of diseases that can cause
chronic pain are rheumatoid arthritis, systemic lupus erythematosus (SLE), and Graves'
disease (Druckman, 2001).
Treatment of chronic pain diseases differs from that of acute pain in that many of
the mechanisms behind the disease and its continuation are unknown. Furthermore,
many of the mechanisms and processes that occur as a result of acute pain have been
established, such as the increased activity of particular endogenous opioid peptides

(Millan et al., 1986). Due to the uncertainty surrounding chronic pain conditions,
researchers are attempting to elucidate a greater understanding of the pain associated with
these diseases. The use of inflammatory agents, including Complete Freund's Adjuvant,
carrageenan, and formalin, are employed to simulate the chronic pain state in laboratory
animals.
Complete Freund's Adjuvant (CFA) is commonly used as the model for
simulating chronic pain in male and female rats. Rats treated with CFA experience
symptoms including inflammation, joint deterioration, and hyperalgesia, creating a
diseased state comparable to Rheumatoid arthritis in humans (Colpaert, 1987). The
inflammation and hyperalgesia produced by CFA results from alterations in several
neuropeptide systems (Cox, 2004). Opioid systems are among those affected by
administration of CFA, causing changes in the receptors, peptides, and mRNAs involved
in producing opioid nociception (Millan, 1986).
The polyarthritic state produced in the weeks following CFA administration
results in significant effects on functions of the opioid systems. Increased levels of
prodynorphin and proenkeplain are observed in the spinal and supraspinal neurons, which
correspond to increased levels of the mRNAs encoding prodynorphin and proenkephalin
(Hollt et al., 1987; Iadarola et al., 1988;). Chronic inflammatory conditions have also
resulted in reductions in [~et~]-enkephalin-like
peptides and levels of proenkephalin A
mRNA in the dorsal root ganglia of arthritic rats (Pohl et al., 1997).

Gonadal Hormones

Whether the pain results from natural or experimental methods of pain, there are
several factors that influence every aspect from sensation to analgesia. The presence of
sex differences between male and female subjects is among these factors. Gonadal
hormones in male and female animals are responsible for both organizational and
activational effects. Organizational effects of steroid hormones occur in the late prenatal
and early postnatal development of rats (Cicero et al., 2002). These effects include
producing sexually appropriate physiology and behavior and making the brain sensitive
to the activational effects of sex hormones during puberty. The activational effects do
not appear until adulthood, when they are responsible for maintaining typical male and
female sexual and other behaviors (Cicero et al., 2002).
Many investigations attempting to determine the influence of the gonadal
hormones on the body have been conducted with varying results. Gonadectomy and
administration of estrogens or androgens are commonly used to study sex differences in
laboratory animals. Krzanowska et al. (2002) and Cicero et al. (2002) successfully
eliminated sex differences in morphine antinociception through the neonatal castration of
male rats and by the administration of androgens to neonatal female rats. However, adult
gonadectomy in both male and female rats did affect morphine analgesia, indicating that
the organizational effects of sex hormones may be responsible for sex differences.
Researchers examining the activational effects of gonadal hormones have discovered less
consistent results in both males and females, showing increases, decreases, and no change
in opioid analgesia after adult gonadectomy (Terner et al., 2002).

Androgens, the primary gonadal hormones present in males, are produced
primarily in the testes and to a lesser degree in the adrenal cortex (Aloisi, 2003). The
primary androgens are testosterone and dihydrotestosterone. Although, generally
considered male sex hormones, androgens are present in much lower levels in females.
Female androgens are secreted from the ovaries and adrenal cortex in small amounts.
This is also true for presence of the female gonadal hormones found in low
concentrations in males (Craft et al., 2004). Aside from the role of testosterone in the
production of male characteristics, it appears that testosterone provides some antiinflammatory function. Lower levels of gonadal and adrenal androgens have been
observed in male and female patients with rheumatoid arthritis when compared to control
subjects (Navarro et a1.,1998; Cutolo et al., 2000). This anti-inflammatory effect of
androgens has also been noted as a common factor in other chronic inflammatory
diseases, like, fibromyalgia, systemic lupus erythematosus (SLE), and Graves' disease
(Aloisi, 2003).
There are two groups of hormones that comprise the female gonadal hormones,
estrogens and progestins. The estrogens (estradiol, estriol, and estrone) and progestins
(progesterone) are both produced primarily by the ovaries (Simpson, 2003). Unlike the
androgens, estrogens are often linked to increased pain sensitivity in females. Korzun et
al. (2000) observed increased pain, perceived stress, and depression associated with
fibromyalgia during the luteal phase of the menstrual cycle of patients corresponding to
high levels of estrogen and progesterone. Estrogens are also responsible for various non-

reproductive effects, including bone formation, cardiovascular function, metabolic rate,
water and salt balance, and hemostasis (Amandusson et al., 1999).
Female hormone levels fluctuate at a much greater degree in females than males,
due to processes such as the menstrual cycle, pregnancy, and menopause. Compared to
males, the female reproductive system undergoes a much greater dynamic of change as
the female progresses through life. Rat ovarian cycles consist of an estrus, or ovulation
phase, lasting about 12 hours; then metestrus, or luteal phase, lasting for one day; then
diestrus, or follicular phase, lasting 1-2 days; followed by proestrus, lasting about 12
hours (Mahesh, 1985). Compared to males, cycling females demonstrate the greatest sex
differences when in the estrus phase, indicated by low estradiol and progesterone levels
(Craft et al., 2004).
Pregnancy and menopause represent the extremes of the female hormonal
spectrum. Pregnant females experience increased levels of progesterone and estrogen.
Conversely, during menopause, females experience a dramatic decrease in the ovarian
production of estrogens (Aloisi, 2003), which makes the aromatization of testosterone to
estradiol the primary source of estrogens (Craft et al., 2004). After menopause, females
rely on the extragonadal aromatization of androgens, like testosterone, androstenedione,
dehydroepiandrosteone (DHEA), and DHEA sulphate (DHEAS) for the production of
estrogens (Zhao et al., 2005).
Correlations between gonadal hormone levels and pain suggest that both
androgens and estrogens have important influences in pain modulation. In humans, this
is seen in the significantly higher prevalence of autoimmune disease in human females

than males (Druckmann, 2001). Also, injection of estradiol into male rats resulted in
higher levels of formalin-induced licking than in control rats (Aloisi and Ceccarelli,
2000), suggesting a pronociceptive effect of estrogen. Given the dramatic sex differences
seen in prevalence of chronic pain diseases it seems likely that the ability of the gonadal
hormones results from their impact on the opioid system.

Rationale for Study and Hypotheses
The majority of research on the endogenous opioid system has examined various
pain assays and the efficacy of different opioid agonists. However, minimal attention has
been focused at the effects of the gonadal hormones and their impact on the opioid
peptide system. Sex differences in response to pain have been observed in both human
and animal models (Przewlocki R. and Przewlocki B., 2001). Most studies have
concluded that opioid analgesia is greater in males than females and also that females
exhibit a greater nociceptive and hyperalgesic response to inflammatory agents and
nociceptive stimuli (Wiesenfeld-Hallin, 2005). Many studies have found that these sex
differences have been eliminated through the manipulation of gonadal steroids through
castration in males and testosterone administration in females (Cicero et al., 2002;
Krzanowska et al., 2002).
The present study was designed to determine any effects of the gonadal hormones
on the opioid receptor protein levels of CFA on treated male and female Lewis rats.
Following a paw pressure pain assay, the midbrain and spinal cord tissues were collected
for comparison of MOR, DOR, and KOR protein levels. Receptor protein levels should

provide an estimate of the receptor density, which should be decreased in animals
experiencing pain. It was hypothesized that male rats would feel less pain than female
rats regardless of the presence of gonadal hormones and gonadectomy, which would
result in a decreased pain threshold in male arthritic and nonarthritic rats.

Materials and Methods

Subjects
Hormonally intact male and female Lewis rats approximately 60 days of age were
obtained from Charles Rivers Laboratories (Raleigh, NC). Castrated (CAS) and
ovariectomized (OVX) rats were also obtained from Charles Rivers Laboratories
(Raleigh, NC), with the surgeries being performed when the rats were approximately 50
days of age. All rats were allowed to acclimate to the vivarium until approximately 70
days of age, at which time the experiment commenced. Rats were individually housed,
had free access to food and water, and were maintained on 12112h lightldark cycle.

CFA Administration
On Day 1 animals were injected intradermally in the base of the tail with 0.1 ml of 5.0
mglml Complete Freund's Adjuvant (CFA) (heat-killed Mycobacterium; Difco
Laboratories, Detroit, MI) or 0.1 ml of vehicle (VEH) (mineral oil).

Paw Thickness and Nociceptive Sensitivity Testing.
Paw thickness (mm) of the left and right hindpaws was determined with a digital caliper.
Nociceptive sensitivity was assessed on Day 19 by determining thresholds in response to
mechanical pressure applied to the hindpaws of the rats. Rats were lightly restrained in a

towel and a mechanical stimulus was applied with an analgesy meter (Ugo Basile,
Varese, Italy), a device with a dome-shaped plastic tip (diameter = 1 mm) that applies a
linearly increasing pressure (g) to the dorsal surface of the hindpaw, with the tip applied
to the region of the paw just proximal to the third digit. On three separate occasions prior
to Day 12 each rat was habituated to the paw pressure procedure. Habituation involved
wrapping the rat lightly in a towel and placing one hindpaw on the plinth under the domeshaped plastic tip. Increasing pressure was then applied until a withdrawal response was
initiated. This habituation procedure was repeated for the other hindpaw. On Day 19,
paw pressure thresholds were determined for both the left and right hindpaws with the
order of testing counterbalanced across animals.

Estrous Cycle Phase Determination
Estrous cycle phase determination was determined in female rats by vaginal lavage on
Day 19. The stages were identified based upon the type of cells detected. Proestrus
phase was signified by a majority of round, nucleated cells, and an absence of leukocytes.
Estrous phase was signified by a majority of cornified cells, and an absence of
leukocytes. Metestrus phase was signified by the presence of round nucleated cells,
cornified cells, and leukocytes. Diestrus phase was signified by the presence of all three
cell types seen in metestrus, however, the number of cells in this phase was greatly
reduced.

Tissue Collection
Following nociceptive testing, the rats were killed by rapid decapitation 19 days after
complete Freund's adjuvant inoculation. Midbrain and spinal cord tissues were removed
and immediately fiozen at -80°C.

Tissue Preparation
For each assay, spinal cord and midbrain tissue were thawed and homogenized in 10 ml
cold IP buffer with protease inhibitors, followed by centrifugation at 3,500 x g for 12
minutes at 4OC. The supernatant was transferred into clean 27 x 115 mm plastic
centrifuge tubes and centrifuged at 20,000rpm for 33 minutes at 4OC. The supernatant
was discarded, and the pellet was resuspended in IPIdetergent buffer, using 350 p1 for
spinal cord tissue and 425 pL for midbrain tissue. To solubilize the pellets, they were left
on ice and vortexed vigorously every 5 minutes for 1 hour. Tissues were then centrifuged
at 12,000 rpm for 15minutes at 4OC. The supernatant was pipetted into 17 x 100 mm
plastic culture tubes. Protein assays were conducted with the Bio-Rad Detergent
Compatible assay kit. Protein samples were aliquotted and stored at -80°C.

Western Immunoassays
Electrophoresis was performed with a standard Laemrnli method. Samples were diluted
1:1 with 2X sample buffer and loaded into a 1.5 mrn 8% SDS-PAGE gel. Protein (8 pg)
was loaded into each gel for each of the receptors, MOR, DOR, and KOR. Following

protein separation, transfer onto Immobilon-P PVD membrane (Millipore, Bedford, MA)
was performed by the tank method. Blots were reversibly stained with Ponceau solution
(Sigma Chemical Co.) blocked at least one hour in casein blocker in TBS (Pierce,
Rockford, IL). The blots were incubated in the appropriate opioid receptor antibody
concentrations overnight at room temperature (KOR, 1:2000 in casein, DOR, 1:10,000 in
casein, MOR, 1:125 in casein). After washing three times in Tris-buffered saline plus
0.5% Tween 20 (TBST) for 5 minutes, the blots were incubated in horseradish
peroxidase-conjugated goat anti-rabbit IgG antiserum (Sigma Chemical Co.) at 1:50,000
dilution in casein for one hour at room temperature. Blots were washed again three times
in TBST and then incubated for 5 minutes in Supersignal CL-HRP chemiluminescence
(Pierce, Rockford, IL). Blots were then exposed on XAR-2 film (Eastman Kodak,
Rochester, NY). Bands were quantified with scanning densitometry, and comparisons of
the optical density values were performed by unpaired t-tests.

Antibodies

Anti-MOR-antibody (anti-acetyl-EAETAPLP-amide,C-terminal) was obtained from
Research and Diagnostic Antibodies (Berkley, CA). Anti-DOR (anti-acetylCGRQEPGSLRRPRQA-amide, C-terminal, anti-KOR (anti-acetylSREKDRNLRRJTKL-amide, C-terminal) antibodies were obtained from Biosource
International (Camarillo, CA).

Data Analysis
Following quantification of bands with scanning densitometry, the optical density ratios
were calculated by dividing the respective GAPDH optical densities by the optical
density of MOR, DOR, and KOR. The optical densities were reported as mean +. S.E.M.
and tested for significance (p < 0.05) with the independent sample t-test in SPSS, Version
12.0 for Windows.

Results

3.1. Paw pressure testing prior to tissue collection
Male and female Lewis rats were tested to determine the effect of gonadectomy in
vehicle and CFA treated rats using the paw pressure test. CFA-treated (arthritic "Arth") animals, denoted by black bars, had significantly lower pain thresholds in both
males and females regardless of the presence of gonadal hormones (Figure 1). A
significant increase in the pain threshold of arthritic female rats was observed after
ovariectomy. No significant differences were observed between intact and castrated nonarthritic or arthritic male rats. No significant difference was observed between nonarthritic intact and ovariectomized females.

3.2. Effect of arthritis on female rats.
Figure 2, Panels A, B, and C shows the optical density ratios of MOR, DOR, and
KOR standardized to the GAPDH loading control. Non-arthritic rats are shown in white
bars and arthritic rats in black bars. In Fig. 2.A no significant differences were observed
in the midbrain ("Brain") of female Lewis rats when tested for MOR protein. Receptor
protein levels in the spinal cord ("Cord") of non-arthritic gonadectomized ("GDX)
female rats were significantly lower (p < 0.05) than in the arthritic gonadectomized
females. No significant differences were observed in DOR protein levels in the midbrain

or spinal cord tissues of non-arthritic and arthritic animals regardless of gonadectomy
(Panel B).
In Panel C, no significant differences were observed in the KOR protein of the
midbrain tissue in intact and gonadectomized females. However, there were significant
differences between the nonarthritic and arthritic spinal cord tissue of both intact and
gonadectomized female rats. In the case of the intact rats, the development of arthritis
resulted in a significant decrease in KOR protein in the cord. Gonadectomized rats
conversely had lower levels of KOR protein in the non-arthritic rats compared to the
intact non-arthritic rats. The induction of arthritis in the gonadectomized animals
significantly increased KOR protein level in the spinal cord.

3.3 Effect of arthritis on male rats.
Figure 3, panels A, B, and C show the optical density ratios of MOR, DOR, and
KOR proteins, respectively, standardized to the GAPDH loading control in male Lewis
rats. In Panel A, the MOR protein level of the intact arthritic males is significantly higher
than the intact non-arthritic midbrain tissue, but no difference is observed in the midbrain
tissue of the castrated ("GDX") male rats. In the male spinal cord tissue, the MOR
protein levels showed no significance differences between intact or castrated rats.
There were no significant differences observed in the male DOR protein levels in
the midbrain and spinal cord tissue, as seen in Panel B. (in arthritic or non-arthritic rats).
The KOR protein level (Panel C) was not significantly different in the intact male
midbrain tissue, although there is a trend for arthritis to decrease KOR protein levels in

the midbrain. Gonadectomized arthritic males displayed higher KOR protein levels than
the gonadectomized non-arthritic rats. Significantly higher levels of KOR protein were
found in the spinal cord tissue of the intact non-arthritic male rats than the intact arthritic
rats. Among the castrated arthritic and non-arthritic male spinal cord tissue no significant
differences were observed.

Sex Differences in MOR, DOR, and KOR
Male and female data were directly compared in Fig 4, Panels A, B, and C to
determine variations in MOR, DOR, and KOR protein levels. These figures display the
male and female data comparing the midbrain ("MB") and cord tissues of arthritic and
non-arthritic animals and of intact and gonadectomized animals. Fig 4.A shows the
comparison of the MOR protein, in males and females, which shows significantly higher
(p < 0.05) protein levels in the midbrain tissue of intact non-arthritic and arthritic male
rats and also in nonartlwitic gonadectomized male rats versus female rats. The midbrain
(MB) data also indicated a near significant difference between the MOR protein levels of
male and female arthritic gonadectomized rats (p = 0.05). Male MOR protein levels were
significantly higher in all spinal cord tissue versus that of female rats.
No significant differences were observed between male and female midbrain
DOR protein levels, as seen in Fig B. In the spinal cord, intact female rats had
significantly higher DOR protein levels in both nonarthritic and arthritic rats compared to
male rats. However, no significant differences were observed in the spinal cord DOR
protein levels of arthritic and nonarthritic animals after gonadectomy, although the trend

remains that the female DOR proteins are higher than male in cord. According to Fig 4.,
although intact male and female rats had similar KOR protein in MB when no arthritis
was present, gonadectomy and arthritis significantly reduced KOR proteins in males, but
had no effect on female MB KOR protein. Female KOR protein levels were significantly
higher in all spinal cord tissue versus that of male rats.
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Figure 1. The effect of gonadectomy and CFA treatment in male and female rats on paw
pressure thresholds on day 19. Brackets indicate S.E.M. Asterisk (*) indicates a
significant difference (Bonferroni's post hoc test) from same day VEH treatment group.
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Figure 2. Effect of arthritis on MOR, DOR, and KOR protein levels in female rats are
shown in Panels A, B, and C, respectively. The arthritic state was induced by an
intradermal injection of Freund's adjuvant. The midbrain and spinal cord tissue were
removed immediately after decapitation and frozen at -80°C. Bars represent the mean
S.E.M. of 3 female rats. * Indicates significant difference between non-arthritic and
arthritic animals: P < 0.05 by an independent samples t-test.
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Figure 3. Effect of arthritis on MOR, DOR, and KOR protein levels in male rats are
shown in Panels A, B, and C, respectively. The arthritic state was induced by an
intradermal injection of Freund's adjuvant. The midbrain and spinal cord tissue were
removed immediately and stored at -80°C. Bars represent the mean =k S.E.M. of 3 male
rats. * Indicates significant differences between non-arthritic and arthritic animals: P <
0.05 by an independent samples t-test.
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Figure 4. Sex Differences in MOR, DOR, and KOR. Effect of arthritis and
gonadectomy on MOR, DOR, and KOR protein levels in male and female rats are shown
in Panels A, B, and C, respectively. The arthritic state was induced by an intraderrnal
injection of Freund's adjuvant. The midbrain and spinal cord tissue were removed
immediately after decapitation and frozen at -80°C. Bars represent the mean S.E.M. of
3 male or female rats. * Indicates significant differences between non-arthritic and
arthritic animals: P < 0.05 by an independent samples t-test.

*

Table 1. Optical Densities on MOR, DOR, and KOR. The data from scans of optical
densities for the opioid receptor proteins standardized as a ratio to GAPDH are shown in
Table 1. The data were the source for Figures 2-4, previously presented. Values in bold
have significantly lower means than the opposite sex (independent samples t-test).
A Significant difference vs. Intact Non-Arthritic of the same sex and location
Significant difference vs. Intact Arthritic of the same sex location
Significant difference vs Gonadectomized Arthritic of the same sex and location
Brain
Female

Male

Cord
Male

Female

NonArth
Intact
GDX
Arth
Intact
GDX

Delta

Brain
Male

Cord
Female

Male

Female

0.559 a 0.05
0.819 A 0.14

1.095 A 0.08
1.135 0.19

NonArth
Intact
GDX

1.638 A 0.78
0.921 A 0.21

0.844 a 0.20
1.127 a 0.22

Arth
Intact
GDX

Brain
Male
NonArth
Intact
GDX
Arth
Intact
GDX

Cord
Female

Male

Female

Discussion

Historically, most studies investigating sex differences on chronic pain have
focused primarily on the use of opioid agonists and their relative efficacies based on the
presence or absence of pain or gonadal hormones. The present study examined the role
of gonadal hormones on opioid receptor protein levels in intact and gonadectomized,
non-arthritic and CFA-induced arthritic Lewis rats. The presence of the gonadal
hormones was demonstrated to have an important effect on the pain sensation in both
male and female vehicle and CFA-treated rats. Within a single sex, the effect of
gonadectomy also showed to be an important variable in the modulation of pain for males
and females. Significant sex differences were observed in MOR and KOR protein levels,
but not DOR protein.
The effects of CFA-induced hyperalgesia resulted in significantly decreased pain
thresholds in males and females, compared to vehicle treated animals in the paw pressure
test (Fig 1). The spinal cord tissue of female Lewis rats may have a greater role in
modulating pain sensations than midbrain tissues. CFA-treated female rats exhibited an
increase in pain threshold after ovariectomy (Fig. I), which directly corresponds to a
significant increase in KOR protein levels in the spinal cord of arthritic ovariectomized
females (Fig 2, Panel C; Fig 4, Panel C).
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High densities of KOR have been found in the lumbosacral region of the spinal
cord of both rats and humans (Gouarderes et al., 1985). KOR protein levels of female
intact non-arthritic cord tissue are significantly greater than that of the intact arthritic
female; however, this difference is reversed by ovariectomy (Fig 2, Panel C). This trend
toward increased pain threshold was also demonstratedd in MOR protein (Fig 2, Panel
A), indicating a significant effect of the gonadal hormones in female pain modulation.
The present findings also correlate with previous studies that observed an upregulation of
dynorphin in the spinal cord of rats during pregnancy and parturition (Gintzler and
Bohan, 1990; Medina et al., 1993).
Androgens often function as natural anti-inflammatory hormones by suppressing
both humoral and cellular immune responses (Stoffel et al., 2005). The role of the
androgens in pain modulation has primarily been investigated by testing opioid analgesia
in sham and gonadectomized animals. These studies have demonstrated mixed results
after male gonadectomy, including increases, decreases, and no change. In the present
study gonadectomy of males produced a stabilizing effect on opioid receptor protein in
the midbrain and spinal cord of nonarthritic and arthritic rats. That is, MOR and KOR
protein levels in the spinal cord tissue of nonarthritic male rats were significantly higher
than in arthritic rats, however this difference was eliminated by the removal of .the
gonadal hormones (Fig 3, Panels A and C). Gonadectomy produced similar results in the
p receptor protein level in the male midbrain tissue as well (Figure 3, Panel A).

However, the effects of gonadectomy in males was much less profound than in females.
The data on the MOR protein in the midbrain along with MOR and KOR spinal cord

receptor protein levels demonstrate the potential impact of the male gonadal hormones on
opioid receptor proteins and suggests that gonadectomy may increase nociception.
Similarly, Stoffel et al. (2005) reported decreased antinociception after gonadectomy in
male rats treated with p and K opioids, but not 6 opioids. The small magnitude of change
observed in opioid receptor proteins in males following gonadectomy may have little
impact on pain perception.
The presence of sex differences in opioid antinociception has been observed in
both rodent (Kepler et al., 1989; Cicero et al., 1996, 1997; Kest et al., 1999) and nonhuman primate models (Negus and Mello, 1999). In the present study, sex differences
were observed in both the p and K opioid receptor protein levels. The spinal cord tissue
of male rats, regardless of the presence of gonads or arthritis displayed significantly
greater levels of MOR protein levels than females (Fig. 4, Panel A). Male MOR protein
levels were significantly greater in all tested midbrain tissue, except for the near
significant difference (p = 0.05) seen in arthritic gonadectomized male (Fig. 4, Panel A).
These results are consistent with previous studies that suggest greater opioid
antinociception from p agonists in male rats.
Despite these findings, KOR protein levels appear to have a significantly greater
influence on pain sensation in female rats. Female KOR protein levels are significantly
greater than males in all spinal cord tissue. KOR protein levels in female midbrain tissue
were also significantly higher in the non-arthritic ovariectomized and arthritic intact
female rats (Fig. 4, Panel C). According to previous studies, gonadectomized females
displayed decreased opioid antinociception compared to intact females (Cicero et al.,

1996; Craft et al., 1996; Kest et al., 1999), which may have resulted from using yselective agonists, such as morphine, fentanyl, and hydromorphone. The present study
indicates the possibility of greater opioid analgesia in females with K-selective agonists.
It is also important to mention that rodent strain may also function in modulating
sensitivity to opioid-induced antinociception and determining the magnitude of sex
differences. In previous studies, F344 and Lewis strains demonstrated greater sex
differences than the Sprague-Dawley strain in potency and effectiveness of p-opioid
agonists (Bartok and Craft, 1997; Barrett et al., 2001; Cook et al., 2000). The
significantly greater KOR protein levels seen in the Lewis rats used in the present study,
may correlate to the slightly more sensitive effects of U50,488, a kappa agonist, on
female Lewis rats compared to male Lewis rats observed in a previous study (Barrett et
al., 2001).
The overall findings of the present study provide strong evidence for the
importance of the gonadal hormones in the modulation of pain sensation in arthritic and
nonarthritic Lewis rats, especially in the female rat. The removal of gonadal hormones
appears to have opposite effects in males and females; causing decreased pain in females
and increased pain in males. Under these conditions, pain sensation in males or females
does not appear to be modulated by delta opioid receptor proteins. The presence of
significantly greater MOR protein levels in male rats is in agreement with previous
studies. However, a major implication of the present study is the greater levels of KOR
protein in female rats, possibly indicating that usage of more K-selective opioid agonists,

like U50,488, butorphanol and pentazocine, may demonstrate greater efficacy in
providing pain relief to females. The administration of K-selective opioid agonists may
also eliminate many of the negative effects of p-opioid agonists that women experience,
including nausea, emesis, and constipation.
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